Perivascular graft heparin delivery using biodegradable polymer wraps

Area of Science:

• Biomaterials Science
• Vascular Biology
• Drug Delivery Systems

Background:

• Heparin is a key inhibitor of vascular injury responses but faces clinical limitations due to its short half-life and complex pharmacokinetics.
• Current heparin delivery methods, including oral and systemic administration, are insufficient for effective therapeutic outcomes, leading to degradation or uncontrolled bleeding.
• Existing local delivery systems lack precise control over release kinetics, posing challenges for site-specific heparin therapy.

Purpose of the Study:

• To design and develop a novel biodegradable system for perivascular heparin delivery with controlled release kinetics.
• To investigate the factors influencing heparin release from the developed system.
• To evaluate the efficacy of this heparin delivery system in inhibiting vascular smooth muscle cell proliferation and controlling vascular injury in animal models.

Main Methods:

• Development of a biodegradable system comprising heparin-encapsulated poly(DL lactide-co-glycolide) (pLGA) microspheres within an alginate gel.
• In vitro assessment of heparin release kinetics over 25 days.
• Utilized Gel Permeation Chromatography (GPC) and Scanning Electron Microscopy (SEM) to monitor degradation and correlate with release.
• Assessed the inhibition of bovine vascular smooth muscle cell growth in tissue culture.
• Evaluated vascular injury in denuding and interposition vascular graft animal models.

Main Results:

• The novel system demonstrated controlled heparin release in vitro for up to 25 days.
• Degradation monitoring using GPC and SEM correlated well with observed heparin release kinetics.
• Heparin-releasing gels effectively inhibited vascular smooth muscle cell growth in a dose-dependent manner.
• The system successfully controlled vascular injury in animal models, even when standard methods caused bleeding.

Conclusions:

• The developed biodegradable system provides a novel method for controlled perivascular heparin delivery.
• This system effectively inhibits vascular smooth muscle cell proliferation and mitigates vascular injury.
• The findings suggest potential applications for this system in treating accelerated arteriopathies and understanding vascular disease mechanisms.